Healio: How do treatment goals differ for younger vs. older patients with type 2 diabetes? Buse: The most important aspect of tailoring treatment for younger vs. older patients is understanding ...

LONDON, April 11, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences, a clinical stage biotechnology company advancing innovative therapies for diabetic eye diseases, today announced that the first patient ...

Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes. Newer glucose-lowering medications glucagon-like peptide-1 receptor ...